baber/WOPTO huggingface dataset:
Patent CA-2299169-A1 (CA)
Inventor: LAFANECHERE LAURENCE
IPC: C12Q1/37
Filed: 1998-07-24
Abstract: The invention concerns the use of cells wherein the tubulin tyrosination-detyrosination cycle is modified, for screening and selecting inhibitors of the tubulin-carboxypeptidase, their use as anti-cancer agents and the screening method using said cells. Said cells, which over-produce tubulin-glu, are adapted for selecting or screening products inhibiting the tubulin-carboxypeptidase activity (TCP).
Patent CA-2299960-A1 (CA)
Title: Solution purification method for electrolyte
Inventor: IMAMURA MASAKI
IPC: C22B30/00
Filed: 2000-02-29
Abstract: A solution purification method for an electrolyte comprising the steps of dividing a chelate resin having a volume corresponding to the quantity of Sb and Bi to be adsorbed into a plurality of columns, bringing an electrolyte into contact with the chelate resin in the columns to adsorb the Sb and Bi for removing, respectively, and subjecting a predetermined number of columns which have completed adsorption among the plurality of columns, to washing in turn, such that the columns are fed in series with a washing solution.
Patent CA-2303002-A1 (CA)
Inventor: SAKAKI YOSHIYUKI
IPC: C07K14/47
Filed: 1998-09-11
Abstract: A human gene and a mouse gene corresponding to Drosophila period gene which has been known as participating in the circadian period. The proteins and DNAs are applicable to the treatment of diseases relating to the circadian rhythm such as sleep stage regression syndrome, sleep stage progression syndrome, non-circadian agrypnotic syndrome, irregular agrypnotic disorder and time difference syndrome (i.e., so-called jet lag), labor and health management of those working until late at night irregularly, prevention of night poriomania in dementia, etc.
Patent CA-2305168-A1 (CA)
Inventor: DOLLE THOMAS
IPC: H04J11/00
Filed: 2000-04-14
Abstract: The invention is based on the synchronization and training preambles. The optimizes sequence is very suitable to generate a preamble or a part (also called field) of it by mapping the sequence to the appropriate subcarriers of a OFDM symbol with a FFT size of 64. The benefit of the invention is the improved timing accuracy when the autocorrelation result in the B-FIELD is used for synchronization. The time domain structures of the preambles according to the prior art are not changed according to the invention. The advantages of the present invention can be summarized as follows:      The invention proposes an OFDM based synchronization symbol with a low peak-to-average-power-ratio and a small dynamic range, - the synchronization performance (timing accuracy compared to current preambles) is improved, - the specified time domain preamble structures according to the prior art are not modified, and - no extra complexity is needed.
Patent CA-2305612-A1 (CA)
Title: Halogen substituted tetracyclic tetrahydrofuran derivatives
Inventor: ANDRES-GIL JOSE IGNACIO
IPC: C07D493/04
Filed: 1998-10-06
Abstract: This invention concerns the compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is zero, 1, 2, 3, 4, 5 or 6; X is CH2 or O; R1 and R2 each independently are hydrogen, C1-6alkyl, C1-6alkylcarbonyl, halomethylcarbonyl or C1-6alkyl substituted with hydroxy, C1-6alkyloxy, carboxyl, C1-6alkylcarbonyloxy, C1-6alkyloxycarbonyl or aryl; or R1 and R2 taken together with the nitrogen atom to which they are attached may form a morpholinyl ring or an optionally substituted heterocycle; R3 and R4 are both halogen; or R3 is halogen and R4 is hydrogen; or R3 is hydrogen and R4 is halogen; and aryl is phenyl or phenyl substituted with 1, 2 or 3 substituents selected from halo, hydroxy, C1-6alkyl and halomethyl. The compounds of formula (I) may be used as therapeutic agents.
Patent CA-2306005-A1 (CA)
Title: Gel preparation containing polystyrene-sulfonates
Inventor: HIGUCHI FUMIO
IPC: A61K9/06
Filed: 1998-10-15
Abstract: The invention relates to a polystyrene sulfonate- containing gel preparation for therapy of hyperpotassemia, wherein the particle size of polystyrene sulfonate is controlled within the range of at least 5 - 100µm, the viscosity of its solution before gelation is adjusted depending on the particle size by adding a thickening agent, and the polystyrene sulfonate particles after gelation is uniformly dispersed therein.  More preferably, a water-displacing agent is contained, whereby the amount of water in the preparation is reduced. This gel preparation does not cause a sense of foreign matter or a sense of roughness in the oral cavity upon ingestion and intake, thus making it unnecessary to drink water for ingestion, and further its water content is low, so that control of water intake is made easy, even in the case of a patient with renal insufficiency who is subjecting to restriction in intake of water to significant improve the quality of life of the patient.
Patent CA-2307460-A1 (CA)
Inventor: EGAN PATRICK
IPC: E02D15/08
Filed: 2000-05-09
Abstract: "In the course of building roads and other major earth excavations, it is known that erecting geo-textile fabric in front of running water will filter the silt and larger earthen particles from the water downstream from the fabric. In this invention two slats or a single stake of material will be provided on which geo-textile fabric will be attached at regular intervals. The slats will then attach to a reusable stake or the fabric may be attached directly to the single disposable stake. By providing these slat and stake combinations, the slats and fabric will be removable from the silt and the stakes will be reusable; or the disposable stake and fabric may be removed and discarded."
Patent CA-2307820-A1 (CA)
Title: Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
Inventor: CHAKRABARTI RANJAN
IPC: A61P3/06
Filed: 1998-01-23
Abstract: Novel .beta.-aryl-.alpha.-oxysubstituted alkylcarboxylic acids of formula (I) and compositions containing them. The compounds have hypolipidemic, antihyperglycemic uses.
Patent CA-2308827-A1 (CA)
Inventor: OLPE PETER R
IPC: H04L12/40
Filed: 2000-05-12
Abstract: A ring-bus transition 100 is provided which for switching signals between inputs 140-144 and outputs 180-185. First, signals are received at a number of inputs 140-144. Each input is coupled to a demod 130-134. Each demod is coupled to a communication ring 151-160 which is in turn coupled to a bridge 190. Signals received at the inputs 140-144 are demodulated at the demods 130-134 and then sent via the communication rings 151-160 to the bridge 190. The bridge relays the signals to a communication bus 195 which in turn relays the signals to output processors 170-175. Each output processor 170-175 may receive and stores signals destined for it in a memory queue 230. The signals may then be output in the order they arrive or in some other order based on a priority signal. Additionally, each communication ring 151-160 may be closed by connecting the bridge 190 to the first input on each loop. Closing the loop allows each input to perform error checking on the transmitted signal and, in the case of an error, re-transmit or transmit an error message.
Patent CA-2308848-A1 (CA)
Inventor: WEIHRAUCH GEORG
IPC: D01F8/04
Filed: 1998-11-03
Abstract: L'invention concerne un monofilament qui présente des forces de liaison secondaire réduites et est constitué d'au moins deux polymères coextrudés, pour produire des poils de brosserie ou des éléments nettoyants interdentaires pouvant être refendus essentiellement en sens axial au moyen de forces mécaniques. L'invention vise à obtenir des fentes ou des repères bien définis. A cet effet, les deux polymères contenus dans le monofilament présentent une configuration géométrique régulière avec des couches limites s'étendant sensiblement en sens axial, dans lesquelles sont présentes les forces de liaison secondaire réduites.
Patent CA-2308971-A1 (CA)
Title: Automatic compliance-testing system for desktop designed consumer packing
Inventor: FURTADO MARIA D C R
IPC: G06V30/224
Filed: 2000-05-16
Abstract: An automatic compliance testing system for desktop designed consumer packaging. The automatic compliance testing system comprises an Encapsulated PostScript TM barcode file which includes an executable self-checking module which tests the barcode file for specification violations to the UPC barcode definition. The results of the self-checking operation are communicated to a checklist module. The checklist module is an executable module which generates a checklist that displays the test results. The checklist may be placed at any location, scaled, mirrored or rotated within the design document but in most cases adjacent to or outside the boundaries of the consumer packaging being designed. The automatic compliance testing system provides the capability for a PostScript TM imaging device or PostScript TM RIP software package to check compliance of the defined barcode with predetermined specifications and to indicate problems with the barcode which would result in a failed Certificate of Conformity and/or attendant non-compliance penalties.
Patent CA-2310047-A1 (CA)
Inventor: GALLETTI CESARE
IPC: B21C47/24
Filed: 1998-11-03
Abstract: Carousel winding reel (10) for thin or very thin strip/sheet, up to 0.5 mm, hot rolled and leaving in a continuous strip from a rolling train at speeds of 20 metres per second and more, the reel (10) comprising a pair of mandrels (11a, 11b) arranged with their respective axes parallel to each other (12a, 12b) and associated with a structure (13) able to rotate around a longitudinal axis (14) substantially between the axes (12a, 12b), the rotatable structure (13) including a front body side (28a) and a rear body side (28b), the mandrels (11a, 11b) including alternatively a position of winding and a stand-by position, the mandrels (11a, 11b) and the rotatable structure (13) cooperating with respective drive means and with a beam structure (17) attached to the floor, wherein the drive means of the mandrels (11a, 11b) consist of respective motors (15a, 15b) each of which is arranged coaxially with the respective mandrel (11a, 11b) and is positioned between the said body sides (28), the motors (15) including a stator (215) and a rotor (115), the body sides (28) including the seatings (29) of the main bearings (18) of the rotor (115), the stator (215) being connected to at least one body side (28) by anti-torsion means (27).
Patent CA-2319144-A1 (CA)
Inventor: COMOGLIO PAOLO
IPC: C07K14/475
Filed: 1999-01-28
Abstract: Recombinant proteins deriving from recombination of structural domains deriving from alpha and beta subunits of HGF and/or MSP growth factors. The recombinant proteins of the present invention contain domains selected from HGF and MSP to protect cells from death (apoptosis) induced by chemotherapeutics.
Patent CA-2321137-A1 (CA)
Inventor: LE QUERE PHILIPPE
IPC: F16L21/08
Filed: 2000-09-25
Abstract: The coupling consists of a tubular sleeve (1) with one end (3) connected to another component in a pressurised fluid circuit, such as another pipe, a tank or a pump, and its other end (4) designed to receive a first pipe (C), and equipped with a seal and end stop. The sleeve also contains a cuff (7) which is elastically deformable, at least in an axial direction, and acts as a seal. One end (7.2) of the cuff has an inner annular shoulder (14) forming an end stop for the pipe (C), and a cylindrical inner surface adjacent to the shoulder which fits against the outer surface of the pipe, being of slightly smaller diameter than it. The other end of the cuff has an outer shoulder (11) which fixes it inside the sleeve.
Patent CA-2321894-A1 (CA)
Title: Electrochromic display device
Inventor: CHANDRASEKHAR PRASANNA
IPC: G02F1/15
Filed: 1999-02-18
Abstract: An electrochromic device is provided having an electrochromic conducting polymer layer in contact with a flexible outer layer. A conductive reflective layer is disposed between the electrochromic conducting polymer and a substrate layer. A liquid or solid electrolyte contacts the conductive reflective layer and a counter electrode in the device. A liquid electrolyte may comprise, for example, a mixture of sulfuric acid, poly(vinyl sulfate), and poly(anethosulfonate). A solid electrolyte may comprise, for example, a mixture of sulfuric acid, poly(vinyl sulfate), poly(anethosulfonate), and poly(vinyl alcohol). The electrochromic conducting polymer layer may comprise, for example, poly(diphenylamine), poly(4-amino biphenyl), poly(aniline), poly(3-alkyl thiophene), poly(phenylene), poly(phenylene vinylene), poly(alkylene vinylenes), poly(amino quinolines), or poly(diphenyl benzidine) and one or more dopants such as poly(styrene sulfonate), poly(anethosulfonate), poly(vinyl sulfate), p-toluene sulfonate, trifluoromethane sulfonate, and poly(vinyl stearate).
Patent CA-2322370-A1 (CA)
Title: Bacillus species for reducing fusarium head blight in cereals
Inventor: SCHISLER DAVID A
IPC: A01N63/02
Filed: 2000-10-05
Abstract: Microbial antagonists that will suppress Fusarium head blight (head scab) in cereals, particularly in wheat and barley have been identified. Two superior antagonists include NRRL B-30210 and NRRL B-30211.
Patent CA-2324214-A1 (CA)
Title: Thread joint for percussive drilling
Inventor: OLSSON URBAN
IPC: E21B17/042
Filed: 1999-03-19
Abstract: The present invention relates to a thread joint, a male portion, a female portion and a method for manufacturing a product for percussive drilling. The threaded connection comprises at least one substantially cylindrical external thread and a substantially cylindrical internal thread. The external thread is provided on a spigot (13) of a drill string component. The thread comprises thread ends (30) provided in connection with an associated full profile thread (14A). Said thread comprises thread flanks (30A, 30B, 14B, 14C).  At least one of the substantially cylindrical threads comprises at least one thread end (30) the shape of which differs from the shape of the full profile thread (14A). Each thread flank (30A, 30B) of the thread end (30) has a profile, which differs from the profile of the associated flanks (14B, 14C) of the full profile thread (14A).
Patent CA-2324656-A1 (CA)
Inventor: VON MELCHNER HARALD
IPC: A61K38/00
Filed: 1999-03-31
Abstract: The invention relates to a novel protein product of the NET1 locus. The novel protein has transforming activity in the NIH3T3 focus-forming assay and is suitable as a point of attack for influencing carcinogenesis and treating cancer by therapy, as well as for influencing apoptosis. The cloned DNA also provides a possibility for diagnosing cancer since transcripts of the transforming protein can be detected in patient samples.
Patent CA-2326867-A1 (CA)
Title: Method and apparatus of controlling the actuation of a compression brake
Inventor: MICKIEWICZ MATTHEW G
IPC: F02D13/04
Filed: 2000-11-21
Abstract: The present invention provides a method and apparatus for controlling an actuation of a compression brake associated with a combustion engine.    The engine includes a fluid circuit for delivering a fluid to the compression brake. The engine also includes a cylinder having an associated exhaust valve. The method includes the steps of establishing a desired timing of an actuation of the brake, determining an air pressure of the engine, and determining a desired fluid pressure in response to the timing and the air pressure.
Patent CA-2328163-A1 (CA)
Title: Pressure/force computer controlled drug delivery system and the like
Inventor: BROWN LAWRENCE
IPC: A61M5/145
Filed: 1999-03-05
Abstract: An electric infusion pump system (10) is described. The infusion pump system (10) minimizes pain, tissue damage by monitoring, and controlling hypodermic injection pressure. The infusion pump system (10) is made of a mechanical assembly, and an electrical controller (18). The mechanical assembly consists of a drive mechanism (12) including a housing (22), a motor (66), a mount for the fluid storage device, a load cell (78) to determine fluid pressure, and a coupling (30) to move the fluid storage device's plunger (94); a fluid storage device (90) including a reciprocating plunger (94); and a fluid delivery device including a tube (14), and a needle (17). The electrical controller (18), which controls the overall operation of the system via control of the motor (66), consists of a master microprocessor, a slave microprocessor, an input device for the user, and memory.
Patent CA-2331756-A1 (CA)
Inventor: NORBECK DANIEL W
IPC: A61K31/496
Filed: 1999-05-07
Abstract: The present invention discloses novel compounds, compositions, and methods for inhibiting retroviral proteases and in particular for inhibiting human immunodeficiency virus (HIV) protease. The present invention also relates to compositions and methods for treating a retroviral infection and in particular a HIV infection, and to processes for making such compounds and synthetic intermediates employed in these processes.
Patent CA-2333039-A1 (CA)
Inventor: HOYT ROBERT F JR
IPC: A61F2/958
Filed: 1999-05-21
Abstract: L'invention concerne des procédés et des dispositifs permettant une distribution sélective de produits thérapeutiques dans des régions histologiques ou micro-anatomiques spécifiques des organes. L'introduction du produit thérapeutique dans une cavité creuse d'un organe (par exemple un canal hépato-biliaire ou la lumière de la vésicule biliaire) à une pression, un volume ou une vitesse régulés permet au produit d'atteindre une couche cellulaire prédéterminée (telle que l'épithélium ou l'espace sous-épithélial). Le volume ou la vitesse d'écoulement du produit peut être régulé de manière que la pression intraluminale atteint un niveau seuil prédéterminé au-delà duquel une distribution sous-épithéliale du produit a lieu. Il est également possible de sélectionner une pression plus faible qui ne dépasse pas ce niveau seuil de manière que l'administration soit sensiblement limitée à la couche épithéliale. Cette administration spécifique du site de produits thérapeutiques permet une administration localisée de produits (par exemple dans le tissu interstitiel d'un organe) à des concentrations qui présenteraient un effet toxique systémique par d'autres voies d'administration. Une occlusion du drainage veineux ou lymphatique à la sortie d'un organe, peut également contribuer à prévenir une administration systémique des produits thérapeutiques et accroître l'administration sélective dans les couches cellulaires épithéliales superficielles. Ce procédé permet également de mieux cibler l'administration de vecteurs génétiques sur des cellules dans lesquelles une expression génique est souhaitée. Le dispositif d'introduction comprend une canule comprenant un trocart de perforation de paroi placé dans la lumière. Deux ballonnets gonflables sont pressés contre la paroi de manière à immobiliser la canule et à sceller le site de perforation. Un cathéter équipé d'un ballonnet occlusif est guidé à travers la canule jusqu'au site d'administration du produit.
Patent CA-2333373-A1 (CA)
Title: A device and a method for non-contactual speed measurement on surfaces
Inventor: MODL STEFAN
IPC: G01S7/52
Filed: 2000-03-27
Abstract: The invention relates to a device for contactlessly measuring the speed of a n object (10) moving over a surface (12). The device comprises a device (20) f or emitting a signal with a fixed frequency onto the surface (12) at an angle (.alpha.) in or towards the direction of movement, said angle (.alpha.) bein g altered by the movement of the object (10), and for receiving a Doppler displaced signal reflected by the surface (12). The invention also provides a device (24) for combining a plurality of reflected Doppler displaced signals  that are received one after the other in order to produce a combined spectru m (50; 60, 62, 64). The device for contactlessly measuring speed also comprise s a device (24) for determining the spectral proportion from the combined spectrum with the highest or lowest frequency, exceeding a predetermined signal, and a device (30) for deriving the speed from the frequency of the determined proportion of the spectrum.
Patent CA-2334580-A1 (CA)
Inventor: RUPNIAK NADIA MELANIE
IPC: A61P43/00
Filed: 1999-06-08
Abstract: The present invention provides the use of a NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of bipolar disorder without concomitant therapy with other antidepressant or anti-anxiety agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising the same.
Patent CA-2335259-A1 (CA)
Inventor: WEDDERBURN JAMES WILLIAM
IPC: A47J43/28
Filed: 2001-02-09
Abstract: Herein disclosed is a food-serving utensil comprising; a body having a handle and a food-holding end portion; a scraper for the food-holding end portion of the body; a scraper arm, one end of the arm connecting with the scraper and the other end of the arm connecting with the handle; wherein the scraper arm is moveable with respect to the handle to move the scraper along the food-holding end portion to remove food from the food-holding end portion in use.
Patent CA-2335534-A1 (CA)
Inventor: DE SCHRIJVER STEFAAN A
IPC: G06F3/033
Filed: 1999-06-25
Abstract: The systems and methods described herein provide communication systems that allow for the transmission of voice and data over a wireless network. To tha t end, the systems described herein include a mobile wireless communication system, such as a GSM telephone, and a pen input device capable of collectin g information about an image written on a writing surface and capable of transmitting that information into the wireless communication device.</SDOAB >
Patent CA-2335908-A1 (CA)
Title: Method and apparatus for health signs monitoring
Inventor: TELLER DAVID
IPC: A61B5/00
Filed: 2000-05-03
Abstract: A system for monitoring health signs of an individual detects at least one health sign characteristic of the individual with a sensor unit that is located proximate the individual, produces a health signal from the sensor that indicates at least one health sign of the individual, communicates the health signal from the individual to a receiving apparatus over a wireless connection, provides the communicated health signal to a network, and processes the provided signal at a destination node of the network to indicate if an emergency condition exists. The system sends the health signal to a receiving apparatus over a wireless transmission link and to a computer network, and processes the signal at a destination node to indicate if an emergency condition exists. The components associated with the wireless transmission link are sufficiently small and light weight that the components can be clipped to patient garment or on a harness, which can be worn by the patient without undue discomfort.
Patent CA-2338981-A1 (CA)
Title: Acide nucleique codant la .alpha.1,3-fucosyltransferase et polypeptide jouant le role de cette enzyme
Inventor: SASAKI KATSUTOSHI
IPC: C12Q1/68
Filed: 1999-07-29
Abstract: L'invention concerne: un nouveau polypeptide présentant l'activité d'une  alpha 1,3-fucosyltransférase; un procédé de production dudit polypeptide; un ADN codant ce polypeptide; un procédé de production de cet ADN; un vecteur recombiné obtenu par intégration de cet ADN; un transformant comportant ce vecteur recombiné; un anticorps reconnaissant ledit polypeptide; un procédé pour quantifier ledit polypeptide et une méthode d'immunocoloration faisant appel à cet anticorps; un procédé pour produire une chaîne sucre contenant du fucose, au moyen dudit polypeptide ou dudit transformant; un procédé pour cribler une substance modifiant l'expression d'un gène codant ledit polypeptide; un procédé pour cribler une substance modifiant l'activité dudit polypeptide; et un procédé pour diagnostiquer des affections cérébrales, des maladies des reins, le cancer, etc. au moyen dudit ADN ou dudit anticorps.